Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
G03AA Progestogens and estrogens, fixed combinations
G03AA12 Drospirenone and ethinylestradiol
D09741 Drospirenone and ethinylestradiol <JP/US>
USP drug classification [BR:br08302]
Contraceptives
Oral Contraceptives Combinations
Drospirenone/ Ethinyl Estradiol
D09741 Drospirenone and ethinylestradiol
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
248 Mixed hormone preparations
2482 Estrogens and progestins
D09741 Drospirenone and ethinylestradiol
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09741 Drospirenone and ethinylestradiol
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09741
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09741
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09741
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09741
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D09741